Cite
Salvador-Martín S, Kaczmarczyk B, Álvarez R, et al. Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease. Pharmaceutics. 2021;13(1)doi: 10.3390/pharmaceutics13010077.
Salvador-Martín, S., Kaczmarczyk, B., Álvarez, R., Navas-López, V. M., Gallego-Fernández, C., Moreno-Álvarez, A., Solar-Boga, A., Sánchez, C., Tolin, M., Velasco, M., Muñoz-Codoceo, R., Rodriguez-Martinez, A., Vayo, C. A., Bossacoma, F., Pujol-Muncunill, G., Fobelo, M. J., Millán-Jiménez, A., Magallares, L., Martínez-Ojinaga, E., Loverdos, I., Eizaguirre, F. J., Blanca-García, J. A., Clemente, S., García-Romero, R., Merino-Bohórquez, V., González de Caldas, R., Vázquez, E., Dopazo, A., Sanjurjo-Sáez, M., & López-Fernández, L. A. (2021). Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease. Pharmaceutics, 13(1), . https://doi.org/10.3390/pharmaceutics13010077
Salvador-Martín, Sara, et al. "Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease." Pharmaceutics vol. 13,1 (2021). doi: https://doi.org/10.3390/pharmaceutics13010077
Salvador-Martín S, Kaczmarczyk B, Álvarez R, Navas-López VM, Gallego-Fernández C, Moreno-Álvarez A, Solar-Boga A, Sánchez C, Tolin M, Velasco M, Muñoz-Codoceo R, Rodriguez-Martinez A, Vayo CA, Bossacoma F, Pujol-Muncunill G, Fobelo MJ, Millán-Jiménez A, Magallares L, Martínez-Ojinaga E, Loverdos I, Eizaguirre FJ, Blanca-García JA, Clemente S, García-Romero R, Merino-Bohórquez V, González de Caldas R, Vázquez E, Dopazo A, Sanjurjo-Sáez M, López-Fernández LA. Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease. Pharmaceutics. 2021 Jan 08;13(1). doi: 10.3390/pharmaceutics13010077. PMID: 33429950; PMCID: PMC7830359.
Copy
Download .nbib